此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Interactive Effects of Sodium and Potassium on Vascular Health in Older Adults

2026年6月11日 更新者:Andrea Lobene、Florida State University

Exploring the Interactive Effects of Sodium and Potassium Intake on Vascular Health in Older Adults

The goal of this clinical trial is to determine if a high potassium intake can counteract the harmful effects of excess sodium on endothelial function in older adults with no history of cardiometabolic disease. The main questions it aims to answer are:

  1. Can a high potassium intake attenuate dietary sodium-induced endothelial dysfunction in older adults.
  2. Do changes in endothelial function in response to alterations in sodium and potassium intake differ by sex.

Participants will participants will consume three controlled diets for 10 days each with a minimum 14-day washout between interventions. The order in which participants consume the diets will be randomized. The study diets will vary in sodium and potassium content. Measures of cardiovascular health (blood pressure, arterial stiffness, endothelial function) will be assessed at the end of each diet.

研究概览

详细说明

Cardiovascular health declines with age, especially in postmenopausal females. High sodium diets are a major contributor to cardiovascular disease. Unfortunately, reducing sodium intake can be challenging. It is known that increasing potassium intake can improve cardiovascular disease risk factors in young adults, even if sodium intake remains high. The investigators are hoping to show that potassium can improve cardiovascular health in the context of a high sodium diets in older adults. In this study, participants will consume three 10-day controlled diets in a randomized order. The study diets will include: 1) a low sodium (2,000 mg/day)/low potassium (2,000 mg/day) diet; 2) a high sodium (4,700 mg/day)/usual potassium diet; and 3) a high sodium/high potassium (4,700 mg/day). All food will be provided to participants during these periods, and participants will be instructed not to consume any outside food or beverages. Dietary interventions will be separated by a minimum two-week washout period. Measurements of cardiovascular health will be collected at the end of each diet.

研究类型

介入性

注册 (估计的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:FSU Ann's College
  • 电话号码:850-644-6685

研究联系人备份

  • 姓名:Andrea Lobene
  • 电话号码:850-644-1829
  • 邮箱:alobene@fsu.edu

学习地点

    • Florida
      • Tallahassee、Florida、美国、32306
        • 招聘中
        • Florida State University
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Adults ages 55-75 years
  • At least one-year post-menopause (females)
  • Willing and able to attend laboratory visits

Exclusion Criteria:

  • BMI ≥35 kg/m2
  • Seated blood pressure >135/85 mmHg
  • Current diagnosis or history of cardiovascular disease, diabetes, renal disease, cancer, or major cardiovascular event (e.g. heart attack or stroke)
  • Taking exogenous hormones or hormone replacement therapy
  • Following a vegan or gluten free diet
  • Significant weight loss (>10% of body weight) in the last 6 months, or actively trying to lose weight
  • Current or recent use of a diuretic (within the past 6 months) (e.g. spironolactone, eplerenone)
  • Current or recent use of a potassium binding medication (within the past 6 months)
  • Current use of blood pressure lowering medications (e.g. ACE inhibitors, calcium channel blockers, diuretics, vasodilators, beta blockers, AngII receptor blockers)
  • Current or recent use of the medication trimethoprim
  • Elevated blood lipids (LDL cholesterol ≥190 mg/dL)
  • Elevated serum potassium level (>5.1 mmol/L)
  • Elevated BUN (>22 mg/dL)
  • Elevated creatinine (>1.2 mg/dL)
  • Low eGFR (<90 mL/min/1.73 m²)
  • Current or recent use of tobacco, nicotine, or illicit drugs
  • Radical hysterectomy or oophorectomy (females)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:low Na/low K, high Na/low K, high Na/high K
Three 10-day controlled diets in randomized order, each varying in sodium and potassium content. There is a minimum 2-week washout between diets.
On this intervention, participants will be given a diet that provides 2,000 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 4,700 mg K/day
实验性的:low Na/low K, high Na/high K, high Na/low K
Three 10-day controlled diets in randomized order, each varying in sodium and potassium content. There is a minimum 2-week washout between diets.
On this intervention, participants will be given a diet that provides 2,000 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 4,700 mg K/day
实验性的:high Na/high K, low Na/low K, high Na/low K
Three 10-day controlled diets in randomized order, each varying in sodium and potassium content. There is a minimum 2-week washout between diets.
On this intervention, participants will be given a diet that provides 2,000 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 4,700 mg K/day
实验性的:high Na/high K, high Na/low K, low Na/low K
Three 10-day controlled diets in randomized order, each varying in sodium and potassium content. There is a minimum 2-week washout between diets.
On this intervention, participants will be given a diet that provides 2,000 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 4,700 mg K/day
实验性的:high Na/low K, low Na/low K, high Na/high K
Three 10-day controlled diets in randomized order, each varying in sodium and potassium content. There is a minimum 2-week washout between diets.
On this intervention, participants will be given a diet that provides 2,000 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 4,700 mg K/day
实验性的:high Na/low K, high Na/high K, low Na/low K
Three 10-day controlled diets in randomized order, each varying in sodium and potassium content. There is a minimum 2-week washout between diets.
On this intervention, participants will be given a diet that provides 2,000 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 2,000 mg K/day
On this intervention, participants will be given a diet that provides 4,700 mg Na/day and 4,700 mg K/day

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Endothelial function
大体时间:"Day 11" after each of the three 10-day dietary interventions
Brachial artery flow-mediated dilation as measured in % dilation
"Day 11" after each of the three 10-day dietary interventions
Blood pressure
大体时间:"Day 11" after each of the three 10-day dietary interventions
24-hour ambulatory blood pressure
"Day 11" after each of the three 10-day dietary interventions
Arterial stiffness
大体时间:"Day 11" after each of the three 10-day dietary interventions
Carotid-femoral pulse wave velocity
"Day 11" after each of the three 10-day dietary interventions

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Andrea Lobene、Florida State University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年3月24日

初级完成 (估计的)

2027年6月30日

研究完成 (估计的)

2027年6月30日

研究注册日期

首次提交

2026年6月9日

首先提交符合 QC 标准的

2026年6月11日

首次发布 (实际的)

2026年6月15日

研究记录更新

最后更新发布 (实际的)

2026年6月15日

上次提交的符合 QC 标准的更新

2026年6月11日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • STUDY00006676
  • UF-FSU CTSA Career Development (其他赠款/资助编号:UF-FSU Clinical and Translational Science Award)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅